$SFES
SAFEGUARD SCIENTIFICS INC

2014 Q4 Form 10-K Financial Statement

#000008611516000121 Filed on March 04, 2016

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.500M $4.200M $5.100M
YoY Change -4.26% -12.5% -23.88%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $4.400M $4.200M $5.100M
YoY Change -283.33% -12.5% -23.88%
Operating Profit -$4.485M -$4.177M -$5.069M
YoY Change -4.98% -13.61% -24.51%
Interest Expense -$10.70M -$9.600M -$3.700M
YoY Change -148.42% -7.69% -80.21%
% of Operating Profit
Other Income/Expense, Net $77.00K -$246.0K $1.452M
YoY Change -98.83% -94.18% -153.3%
Pretax Income -$15.11M -$14.01M -$7.348M
YoY Change -163.06% -27.92% -73.87%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$15.11M -$14.01M -$7.348M
YoY Change -163.06% -27.92% -73.87%
Net Earnings / Revenue
Basic Earnings Per Share -$0.73 -$0.68 -$0.35
Diluted Earnings Per Share -$0.73 -$0.68 -$0.35
COMMON SHARES
Basic Shares Outstanding 20.54M shares 20.68M shares 20.77M shares
Diluted Shares Outstanding 20.68M shares 20.77M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $137.2M $151.9M $191.5M
YoY Change -22.75% -6.7% 10.69%
Cash & Equivalents $111.9M $116.7M $164.5M
Short-Term Investments $25.30M $35.20M $27.00M
Other Short-Term Assets $1.700M $1.500M $1.500M
YoY Change 6.25% 15.38% 15.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $138.8M $153.4M $193.0M
YoY Change -22.49% -6.53% 10.7%
LONG-TERM ASSETS
Property, Plant & Equipment $123.0K $95.00K $110.0K
YoY Change -10.87% -40.63% -32.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $136.0M $142.2M $121.7M
YoY Change 22.91% 27.13% 18.46%
Other Assets $2.075M $2.156M $2.834M
YoY Change -47.15% -23.71% -7.9%
Total Long-Term Assets $179.6M $178.9M $151.2M
YoY Change 7.64% 13.5% -6.57%
TOTAL ASSETS
Total Short-Term Assets $138.8M $153.4M $193.0M
Total Long-Term Assets $179.6M $178.9M $151.2M
Total Assets $318.5M $332.3M $344.1M
YoY Change -7.96% 3.28% 2.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $226.0K $261.0K $272.0K
YoY Change -7.76% -30.21% 33.99%
Accrued Expenses $2.334M $3.335M $2.307M
YoY Change -3.99% -5.79% -36.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Short-Term Liabilities $6.557M $6.666M $4.954M
YoY Change -19.78% -16.0% -37.59%
LONG-TERM LIABILITIES
Long-Term Debt $50.60M $50.30M $50.00M
YoY Change 2.22% 2.24% 2.04%
Other Long-Term Liabilities $3.507M $3.471M $3.522M
YoY Change -4.78% -8.99% -8.8%
Total Long-Term Liabilities $3.507M $3.471M $3.522M
YoY Change -4.78% -8.99% -8.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.557M $6.666M $4.954M
Total Long-Term Liabilities $3.507M $3.471M $3.522M
Total Liabilities $60.63M $60.42M $58.49M
YoY Change -1.15% -0.9% -3.76%
SHAREHOLDERS EQUITY
Retained Earnings -$544.7M -$529.6M -$515.6M
YoY Change 0.95% -6.02% -5.24%
Common Stock $821.9M $824.7M $825.2M
YoY Change -0.28% 0.04% 0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost) $19.34M $23.15M $23.95M
YoY Change
Treasury Stock Shares 921.0K shares 1.103M shares 1.139M shares
Shareholders Equity $257.8M $271.9M $285.7M
YoY Change
Total Liabilities & Shareholders Equity $318.5M $332.3M $344.1M
YoY Change -7.96% 3.28% 2.39%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income -$15.11M -$14.01M -$7.348M
YoY Change -163.06% -27.92% -73.87%
Depreciation, Depletion And Amortization $100.0K
YoY Change 0.0%
Cash From Operating Activities -$4.700M -$2.700M -$5.000M
YoY Change -4.08% -43.75% 8.7%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$700.0K -$45.20M -$12.90M
YoY Change -101.96% -806.25% -142.43%
Cash From Investing Activities -$700.0K -$45.10M -$13.00M
YoY Change -101.96% -804.69% -142.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 700.0K 0.000 -17.40M
YoY Change -800.0% -100.0% 17300.0%
NET CHANGE
Cash From Operating Activities -4.700M -2.700M -5.000M
Cash From Investing Activities -700.0K -45.10M -13.00M
Cash From Financing Activities 700.0K 0.000 -17.40M
Net Change In Cash -4.700M -47.80M -35.40M
YoY Change -115.31% -896.67% -237.74%
FREE CASH FLOW
Cash From Operating Activities -$4.700M -$2.700M -$5.000M
Capital Expenditures -$100.0K $0.00 $0.00
Free Cash Flow -$4.600M -$2.700M -$5.000M
YoY Change -6.12% -43.75% 8.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0000086115
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20181974 shares
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q2 dei Entity Public Float
EntityPublicFloat
399223768 USD
CY2015 dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Trading Symbol
TradingSymbol
SFE
CY2015Q4 sfe Cash Liabilityfor Performance Based Units
CashLiabilityforPerformanceBasedUnits
0 USD
CY2015Q4 sfe Equity Method Investment Assets Exceed Carrying Value Of Investment
EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment
105600000 USD
CY2001Q4 sfe Future Annual Payment To Chairman And Chief Executive Officer
FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer
650000 USD
CY2015Q4 sfe Impaired Loans Carrying Amount
ImpairedLoansCarryingAmount
0 USD
sfe Loan Impairment Charge
LoanImpairmentCharge
15700000 USD
CY2015Q4 sfe Net Operating Loss Carryforwards Expiring In Year Four
NetOperatingLossCarryforwardsExpiringInYearFour
0 USD
CY2015Q4 sfe Net Operating Loss Carryforwards Expiring In Year One
NetOperatingLossCarryforwardsExpiringInYearOne
0 USD
CY2015Q4 sfe Net Operating Loss Carryforwards Expiring In Year Thereafter
NetOperatingLossCarryforwardsExpiringInYearThereafter
230278000 USD
CY2015Q4 sfe Net Operating Loss Carryforwards Expiring In Year Three
NetOperatingLossCarryforwardsExpiringInYearThree
0 USD
CY2015Q4 sfe Net Operating Loss Carryforwards Expiring In Year Two
NetOperatingLossCarryforwardsExpiringInYearTwo
0 USD
CY2013 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
0 USD
CY2014 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
0 USD
CY2015 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
-246000 USD
CY2015Q4 sfe Partner Companies Not Consolidated In Financial Statements
PartnerCompaniesNotConsolidatedInFinancialStatements
29 partner_company
CY2015Q4 sfe Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes
3 vesting_type
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
226000 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
290000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2334000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2789000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-246000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
819757000 USD
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
817434000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1821000 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1935000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1611000 USD
CY2014Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
9065000 USD
CY2015Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
12771000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1821000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1935000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1611000 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
995000 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1085000 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1184000 USD
CY2014Q4 us-gaap Assets
Assets
318454000 USD
CY2015Q4 us-gaap Assets
Assets
257634000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
138844000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
69668000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66029000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139318000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111897000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32838000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
73289000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27421000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-79059000 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4200000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2014Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
50563000 USD
CY2015Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
51747000 USD
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
9138000 USD
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
6990000 USD
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2700000 USD
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1000000 USD
CY2014Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
68557000 USD
CY2015Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
83042000 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
152921000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
171950000 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1353000 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1369000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
76766000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
84493000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4761000 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1655000 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1484000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.002
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.015
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.001
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1391000 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
152921000 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
171950000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
92000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
190000 USD
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.44
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.85
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.85
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.35
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.347
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.306
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.347
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.001
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.029
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.002
CY2014 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
97405000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
113801000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
403090000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Liabilities And Equity
EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
467117000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-63452000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3997000 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3338000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
403090000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
467117000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
312621000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
357663000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
163016000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
253692000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
160024000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
102596000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
121297000 USD
CY2014 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-108994000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-140801000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
90469000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Assets
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
109454000 USD
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
80050000 USD
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
110829000 USD
CY2013 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
270666000 USD
CY2014 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
319197000 USD
CY2015 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
401182000 USD
CY2014Q4 us-gaap Equity Method Investments
EquityMethodInvestments
135989000 USD
CY2015Q4 us-gaap Equity Method Investments
EquityMethodInvestments
151840000 USD
CY2013 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2014 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21644000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5239000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5069000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4177000 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4485000 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18970000 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4880000 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4754000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3962000 USD
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3958000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17554000 USD
CY2015Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
3800000 USD
CY2014Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
25263000 USD
CY2015Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
31020000 USD
CY2014Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
19365000 USD
CY2015Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
9743000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35525000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31319000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7348000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14006000 USD
CY2014Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15114000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5149000 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14603000 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19022000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11628000 USD
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14271000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59524000 USD
CY2013 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12607000 USD
CY2014Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6808000 USD
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3175000 USD
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8962000 USD
CY2014Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-10006000 USD
CY2014 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15335000 USD
CY2015Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8662000 USD
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13765000 USD
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7635000 USD
CY2015Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9537000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-39599000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1194000 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
369000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
923000 USD
CY2013 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
366000 USD
CY2014 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1443000 USD
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
331000 USD
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
4303000 USD
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1094000 USD
CY2014Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1098000 USD
CY2014Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1103000 USD
CY2014Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1107000 USD
CY2014 us-gaap Interest Expense Debt
InterestExpenseDebt
4402000 USD
CY2015Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1122000 USD
CY2015Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1128000 USD
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1133000 USD
CY2015Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1140000 USD
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
4523000 USD
CY2013 us-gaap Interest Paid
InterestPaid
2900000 USD
CY2014 us-gaap Interest Paid
InterestPaid
2900000 USD
CY2015 us-gaap Interest Paid
InterestPaid
2900000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
2646000 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
470000 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
542000 USD
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
482000 USD
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
407000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
1901000 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
449000 USD
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
640000 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
398000 USD
CY2015Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
448000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
1935000 USD
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
154192000 USD
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
171601000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
60627000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
62129000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
318454000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257634000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6557000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6417000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4252000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24188000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4321000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
90258000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16956000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56989000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21221000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20189000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17749000 USD
CY2014Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
3855000 USD
CY2015Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
2649000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-21644000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5239000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5069000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4177000 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4485000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-18970000 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4880000 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4754000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3962000 USD
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3958000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-17554000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6017000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
397000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
602000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
591000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
584000 USD
CY2015Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3843000 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
230278000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2075000 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1828000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-35525000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5149000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-59770000 USD
CY2013 us-gaap Other Income
OtherIncome
633000 USD
CY2014 us-gaap Other Income
OtherIncome
-124000 USD
CY2015 us-gaap Other Income
OtherIncome
57000 USD
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3507000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3965000 USD
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
383000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30374000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1452000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-246000 USD
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 USD
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31657000 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-388000 USD
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
704000 USD
CY2015Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-84000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
217000 USD
CY2013 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
10464000 USD
CY2014 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
10968000 USD
CY2015 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
15208000 USD
CY2013 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-42000 USD
CY2014 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-137000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
122000 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25036000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4997000 USD
CY2013 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
41838000 USD
CY2014 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
59476000 USD
CY2015 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
70186000 USD
CY2013 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
69883000 USD
CY2014 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
55594000 USD
CY2015 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
29755000 USD
CY2013 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
37000 USD
CY2014 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
59000 USD
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1856000 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1684000 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5810000 USD
CY2013 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1651000 USD
CY2014 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
4684000 USD
CY2015 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1318000 USD
CY2013 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
6434000 USD
CY2014 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2015 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2013 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
38974000 USD
CY2014 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
82822000 USD
CY2015 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
25058000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4417000 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1289000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
676000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17000000 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100000 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
165379000 USD
CY2014 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
55410000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
33640000 USD
CY2013 us-gaap Profit Loss
ProfitLoss
-35525000 USD
CY2014Q1 us-gaap Profit Loss
ProfitLoss
31319000 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-7348000 USD
CY2014Q3 us-gaap Profit Loss
ProfitLoss
-14006000 USD
CY2014Q4 us-gaap Profit Loss
ProfitLoss
-15114000 USD
CY2014 us-gaap Profit Loss
ProfitLoss
-5149000 USD
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-14603000 USD
CY2015Q2 us-gaap Profit Loss
ProfitLoss
-19022000 USD
CY2015Q3 us-gaap Profit Loss
ProfitLoss
-11628000 USD
CY2015Q4 us-gaap Profit Loss
ProfitLoss
-14271000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
-59524000 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
123000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2145000 USD
CY2001Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
26500000 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
43000 USD
CY2014 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
441000 USD
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544746000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-604270000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1821000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1935000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1611000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3900000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
900000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.83
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.02
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.25
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
3.93
CY2014 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.14
CY2015 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.14
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
18.80
CY2014 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
19.95
CY2015 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
19.95
CY2013 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2014 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
29000 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
99000 USD
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
98000 USD
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
158000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4417000 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1289000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
676000 USD
CY2013 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
122000 USD
CY2014 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
25036000 USD
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4997000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
313971000 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
284661000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257827000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
195505000 USD
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
921000 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
993000 shares
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
19341000 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
19570000 USD
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21362000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20975000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20874000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21362000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20975000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20874000 shares
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company&#8217;s ownership interests in and advances to partner companies, income taxes, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts recorded to reflect the Company&#8217;s share of income or losses of partner companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities&#8217; financial statements are completed. For the year ended December 31, 2014, adjustments at a partner company primarily related to revenue recognition amounted to </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">, of which </font><font style="font-family:inherit;font-size:10pt;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;"> related to 2013 and </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to 2012. Management evaluated the quantitative and qualitative impact of the corrections on previously reported periods as well as on the year ended December 31, 2014.&#160; Based on this evaluation, management concluded that these adjustments were not material to the Company&#8217;s Consolidated Financial Statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that the Company&#8217;s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company&#8217;s ownership interests in and advances to partner companies could change in the near term and that the effect of such changes on the financial statements could be material. At December&#160;31, </font><font style="font-family:inherit;font-size:10pt;">2015</font><font style="font-family:inherit;font-size:10pt;">, the Company believes the carrying value of the Company&#8217;s ownership interests in and advances to partner companies is not impaired, although there can be no assurance that the Company&#8217;s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.</font></div></div>

Files In Submission

Name View Source Status
0000086115-16-000121-index-headers.html Edgar Link pending
0000086115-16-000121-index.html Edgar Link pending
0000086115-16-000121.txt Edgar Link pending
0000086115-16-000121-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20151231.xml Edgar Link completed
sfe-20151231.xsd Edgar Link pending
sfe-20151231_cal.xml Edgar Link unprocessable
sfe-20151231_def.xml Edgar Link unprocessable
sfe-20151231_lab.xml Edgar Link unprocessable
sfe-20151231_pre.xml Edgar Link unprocessable
sfe201510k.htm Edgar Link pending
sfe201510kex141.htm Edgar Link pending
sfe201510kex211.htm Edgar Link pending
sfe201510kex231.htm Edgar Link pending
sfe201510kex311.htm Edgar Link pending
sfe201510kex312.htm Edgar Link pending
sfe201510kex321.htm Edgar Link pending
sfe201510kex322.htm Edgar Link pending
sfe201510k_chart-09068.jpg Edgar Link pending
Show.js Edgar Link pending